Flora Growth (NASDAQ:FLGC – Get Free Report) was upgraded by Wall Street Zen from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Saturday.
Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Flora Growth in a research report on Wednesday, October 8th. One investment analyst has rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $30.00.
Get Our Latest Report on Flora Growth
Flora Growth Stock Up 0.5%
Flora Growth (NASDAQ:FLGC – Get Free Report) last issued its quarterly earnings results on Wednesday, November 5th. The company reported ($4.93) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($2.13) by ($2.80). The business had revenue of $9.75 million for the quarter, compared to the consensus estimate of $12.50 million. Flora Growth had a negative net margin of 32.03% and a negative return on equity of 64.02%. On average, research analysts anticipate that Flora Growth will post -0.93 earnings per share for the current year.
Institutional Investors Weigh In On Flora Growth
An institutional investor recently raised its position in Flora Growth stock. Geode Capital Management LLC increased its holdings in Flora Growth Corp. (NASDAQ:FLGC – Free Report) by 1.8% during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 168,572 shares of the company’s stock after purchasing an additional 3,015 shares during the quarter. Geode Capital Management LLC owned 29.16% of Flora Growth worth $98,000 as of its most recent filing with the Securities & Exchange Commission. 36.01% of the stock is currently owned by institutional investors.
About Flora Growth
Flora Growth Corp (NASDAQ: FLGC) is a vertically integrated cannabis and hemp company engaged in the cultivation, extraction, formulation and distribution of cannabinoid-based products. Its portfolio encompasses a broad range of offerings, including oils, vape cartridges, edibles, topicals and patent-pending delivery systems designed for both medical and wellness applications.
Founded in 2018, Flora Growth has established cultivation and processing operations in Uruguay’s greenhouse hubs, complemented by extraction and formulation laboratories in Florida.
Further Reading
- Five stocks we like better than Flora Growth
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- A U.S. “birthright” claim worth trillions – activated quietly
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- NEW LAW: Congress Approves Setup For Digital Dollar?
Receive News & Ratings for Flora Growth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Flora Growth and related companies with MarketBeat.com's FREE daily email newsletter.
